Peloton Therapeutics is translating groundbreaking scientific insights into first-in-class oral medicines to fight cancer and other serious conditions.
Total raised: $40.2M
Investors 4
| Date | Name | Website |
| 13.04.2024 | Vida Ventu... | vidaventur... |
| - | Curative V... | curativeve... |
| - | RA Capital... | racap.com |
| - | The Column... | thecolumng... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.03.2017 | Series D | $22.2M | - |
| 27.07.2011 | Series A | $18M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 21.05.2019 | Term Sheet — Tuesday, May 21 | DEBUT DEAL Mary Meeker has made her first investment out of Bond Capital, the new firm she launched ... | fortune.co... |
| 20.02.2019 | Peloton Therapeutics Secures $150 Million in Series E Financ... | - | vidaventur... |
| 20.02.2019 | Peloton Therapeutics Secures $150 Million in Series E Financ... | - | orbimed.co... |
| 21.03.2017 | Peloton Therapeutics Snags $22.2M | DALLAS, TX, Peloton Therapeutics raised $22.2 million in additional Series D funding, closing the ... | vcnewsdail... |
| 16.03.2017 | Term Sheet — Thursday, March 16 | THE CRAFT BEER BATTLE MOVES TO CHINA Good morning, Term Sheet readers. Today’s column (tipple?) is f... | fortune.co... |
| 15.03.2017 | Peloton Therapeutics Raises $22.2M | DALLAS--(BUSINESS WIRE)--Peloton Therapeutics, Inc., a drug discovery and development company focuse... | citybizlis... |
| 14.03.2017 | Peloton Therapeutics Raises $22.2M in Series D Funding | Peloton Therapeutics, Inc., a Dallas, TX-based drug discovery and development company, raised an add... | finsmes.co... |
| 14.03.2017 | Pushing ahead with cancer drug research, Peloton brings ... | Steven L. McKnight Dallas-based Peloton Therapeutics has bagged an extra $22.2 million for i... | endpts.com... |
| 15.09.2016 | Peloton Therapeutics Lands $52.4M Financing | DALLAS, TX, Peloton Therapeutics, a drug discovery and development company focused on advancing fi... | vcnewsdail... |
| 27.07.2011 | Peloton Therapeutics Completes $18M Series A Financing | Peloton Therapeutics, Inc., a Dallas-based early-stage cancer drug discovery and development company... | finsmes.co... |
Show more